Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
21/09/2026 02:10
BRIEF-Paradigm Biopharmaceuticals Seeks Trading Halt Sept 21 (Reuters) - Paradigm Biopharmaceuticals Ltd PAR.AX:
TRADING HALT PENDING INTERIM ANALYSIS RESULTS FOR PHASE 3 CLINICAL TRIAL
Further company coverage: PAR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Paradigm Biopharmaceuticals
See all newsBrief: Paradigm Biopharmaceuticals Says Board Initiates Voluntary Administration
Brief: Paradigm Biopharmaceuticals Seeks Trading Halt
Australia's Paradigm Biopharmaceuticals slips on discounted placement
Brief: Paradigm Biopharmaceuticals Says Co Completes A$14 Mln Placement
Brief: Paradigm Biopharmaceuticals Requests Trading Halt